Literature DB >> 19603148

Sarcoidosis presenting as "corset-like" myelopathy: a description of six cases and literature review.

Merav Lidar1, Amir Dori, Yair Levy, Zvi Lidar, Joab Chapman, Pnina Langevitz.   

Abstract

Sarcoidosis of the spinal cord is rare, even more so as the initial presentation of the disease. We describe six cases of spinal cord sarcoidosis and delineate a distinguishing feature which may allow for a timely diagnosis. All patients were admitted with complaints of a "corset-like" pressure in the lower chest and later developed cranial nerve palsies (two patients), parasthesias/paraparesis (two patients), fever of unknown origin (one patient), and bilateral proptosis (one patient). Serological tests, immunological screening, cerebrospinal fluid (CSF) analysis, bacteriological and viral testing were performed in all patients. Spinal and cerebral MRI, high-resolution computed tomography (HRCT) of the chest and gallium scan suggested the diagnosis of neurosarcoidosis of the spine while a biopsy of mediastinal lymph nodes, extra-ocular muscles, or spinal cord confirmed it. CSF showed inflammatory signs in 66% of patients and serum ACE levels were increased in a similar fraction. MRI revealed a gadolinium-enhanced thickening of the cord at the thoracic level in three patients whereas three other patients had normal spinal MRI despite similar symptoms. The presence of mediastinal lymphadenopathy on HRCT of the chest suggested the diagnosis in a third of patients. Patients were treated with steroid, immunosuppressive therapy and/or biologic therapies, with complete resolution in one case, improvement in four, and a somewhat deteriorating course, with development of spinal cord atrophy in the final case. As spinal cord involvement of sarcoidosis is extremely rare, making the diagnosis in the absence of systemic disease is challenging. The cases herein described suggest that sensory disturbance in a "corset-like" distribution may be indicative of neurosarcoidosis, especially when accompanied by extra-axial involvement such as cranial nerve palsies. This should prompt an evaluation for systemic involvement, keeping in mind that serum ACE and chest radiographs may be normal in the presence of primarily CNS-limited disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19603148     DOI: 10.1007/s12016-009-8156-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  27 in total

Review 1.  Therapeutic options for sarcoidosis: new and old.

Authors:  Robert P Baughman
Journal:  Curr Opin Pulm Med       Date:  2002-09       Impact factor: 3.155

2.  Spinal cord sarcoidosis.

Authors:  A L Day; G W Sypert
Journal:  Ann Neurol       Date:  1977-01       Impact factor: 10.422

3.  Role of radiology in the diagnosis of neurosarcoidosis.

Authors:  D Pickuth; R P Spielmann; S H Heywang-Köbrunner
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

4.  Long-term follow-up of neurosarcoidosis.

Authors:  D Ferriby; J de Seze; T Stojkovic; E Hachulla; B Wallaert; A Destée; P Y Hatron; P Vermersch
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

5.  Neurosarcoidosis. A report of ten patients illustrating some usual and unusual manifestations.

Authors:  O P Sharma; A Anders
Journal:  Sarcoidosis       Date:  1985-09

Review 6.  Common variable immune deficiency and autoimmunity.

Authors:  Daniel Brandt; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2006-04-24       Impact factor: 9.754

7.  MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy.

Authors:  F J Lexa; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  1994-05       Impact factor: 3.825

8.  Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen.

Authors:  John D Doty; Joseph E Mazur; Marc A Judson
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

9.  Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis.

Authors:  Manica Sodhi; Karla Pearson; Eric S White; Daniel A Culver
Journal:  Respir Med       Date:  2008-10-02       Impact factor: 3.415

10.  Subacute myelopathy as the presenting manifestation of sarcoidosis.

Authors:  J Bogousslavsky; J P Hungerbühler; F Regli; H J Graf
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

View more
  7 in total

1.  Progressive cervical myelopathy as presentation of sarcoidosis.

Authors:  David Price; Richart Harper; Mark C Henderson
Journal:  J Gen Intern Med       Date:  2013-01-31       Impact factor: 5.128

Review 2.  Rosai-Dorfman Disease Isolated to the Thoracic Epidural Spine.

Authors:  Benjamin Kozak; Jason Talbott; Alina Uzelac; Bhavya Rehani
Journal:  J Radiol Case Rep       Date:  2015-11-30

3.  The future of autoimmunity.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 4.  Imaging findings in spinal sarcoidosis: a report of 18 cases and review of the current literature.

Authors:  Neetu Soni; Girish Bathla; Ravishankar Pillenahalli Maheshwarappa
Journal:  Neuroradiol J       Date:  2018-10-12

Review 5.  Isolated intramedullary neurosarcoidosis of the thoracic spine: case report and review of the literature.

Authors:  Bradley S Duhon; Lubdha Shah; Meic H Schmidt
Journal:  Eur Spine J       Date:  2011-05-20       Impact factor: 3.134

6.  Clinical characteristics and outcome of neurosarcoidosis-associated myelitis: A retrospective cohort study and review of the literature.

Authors:  Jessica Y C Nolte; Leroy Ten Dam; Diederik van de Beek; Matthijs C Brouwer
Journal:  Eur J Neurol       Date:  2022-03-03       Impact factor: 6.288

Review 7.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.